Redwood City-based AEGEA Medical has raised $13.3 million in venture funding. The financing round was led by Covidien Ventures, while existing investors Alloy Ventures and Delphi Ventures also participated.
Amy Belt, director of Covidien Ventures, has been added to AEGEA’s board. Funds will be used to complete the company’s product development effort and start the next stage of clinical testing of its new global endometrial ablation system.
Click here for the release from Business Wire.